← Open Payments lookup

CHRISTOPHER DINGESS: Open Payments

NPI 1982016192 · KELLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,063 in 58 payments from 19 companies in 2025. Trend: 2023 $1,868 · 2024 $1,571 · 2025 $1,063

Food & beverage: $1,063
CompanyPaymentsAmount
ABBVIE INC.14$258
Novo Nordisk Inc6$109
Otsuka America Pharmaceutical, Inc.5$98
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$78
Lilly USA, LLC4$76
Abbott Laboratories3$70
PFIZER INC.3$59
Astellas Pharma US Inc3$57
Amgen Inc.3$45
AstraZeneca Pharmaceuticals LP2$31

Products named: VRAYLAR, REXULTI, CAPLYTA, MOUNJARO, Ozempic, NURTEC ODT, Veozah, QULIPTA.

Industry payments across TX — which companies pay providers there.